Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New app helps kidney transplant patients stay healthy from home

NCT ID NCT04969757

Knowledge-focused Sponsor: Assistance Publique - Hôpitaux de Paris Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a smartphone app called Predigraft that helps kidney transplant patients and their doctors monitor the health of the new kidney from home. The app predicts how long the kidney might last and lets patients send in test results and vital signs. The goal was to see how often patients used the app over 12 months. The study included 50 adults who had a kidney transplant at least one month prior.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

50 people

The number who actually took part.

Started

Nov 2021

Finished

Jun 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patient who received a kidney transplant from a living or a deceased donor and transplanted at least 1 month ago * Patient over 18 years of age at the time of inclusion * Stable renal function (glomerular filtration rate\>60 mL/min or decision at physician's discretion) at the time of inclusion * Informed patient with signed consent * Patient with access to an internet connection with a valid email * Enrolled in a social security scheme or beneficiary of such a scheme Exclusion Criteria: * Combined transplant (e.g. kidney-heart transplant, kidney-liver transplant) * Kidney transplant less than 1 month old * Lack of recovery of kidney function following renal transplantation * Patient unable to use the telemedicine tool * Vulnerable participants (minors, protected adults, prisoners) * Patient under State Medical Assistance

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Kidney transplant are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Kidney transplant

Contacts and locations

Locations

  • Hopital Necker - APHP

    Paris, France

  • Hopital Saint Louis - APHP

    Paris, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.